| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |